In this Pharma IQ Miguel Pitarch, Ph.D., Executive Director, Serialisation, Bristol-Myers Squibb, shares his insights on developing an overall serialisation program and why he thinks some organisations still struggle to have clear and robust maps for serialisation and track and trace globally. Pharma IQ: What current trends have you witnessed in pharmaceutical traceability?M Pitarch: I perceive different level of readiness. Some companies are few steps ahead of others. Other companies that initi...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2026
September 9 - 10, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More